Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Kelly, Elizabeth J
9089  Ergebnisse:
Personensuche X
?
1

Author Correction: Molecular and phenotypic characteristics..:

Ahani, Bahar ; Tuffy, Kevin M. ; Aksyuk, Anastasia A....
Nature Communications.  15 (2024)  1 - p. , 2024
Link: https://doi.org/10.1038/..
 
?
2

The genomic evolutionary dynamics and global circulation pa..:

Langedijk, Annefleur C. ; Vrancken, Bram ; Lebbink, Robert Jan...
Nature Communications.  15 (2024)  1 - p. , 2024
Link: https://doi.org/10.1038/..
 
?
3

Seropersistence of SII-ChAdOx1 nCoV-19 (COVID-19 vaccine): ..:

Kulkarni, Prasad S. ; Padmapriyadarsini, Chandrasekaran ; Vekemans, Johan...
Human Vaccines & Immunotherapeutics.  20 (2024)  1 - p. , 2024
Link: https://doi.org/10.1080/..
 
?
4

Seasonal human coronavirus humoral responses in AZD1222 (Ch..:

Stanley, Ann Marie ; Aksyuk, Anastasia A. ; Wilkins, Deidre...
Frontiers in Immunology.  15 (2024)  - p. , 2024
Link: https://doi.org/10.3389/..
 
?
5

Clinical Utility of Remote Camera Video Head Impulse Testin..:

Janky, Kristen L. ; Patterson, Jessie ; Kelly, Elizabeth A.
The Laryngoscope.  , 2024
Link: https://doi.org/10.1002/..
 
?
6

Immunogenicity and safety of beta variant COVID-19 vaccine ..:

Costa Clemens, Sue Ann ; Jepson, Brett ; Bhorat, Qasim E...
The Lancet Microbe.  , 2024
Link: https://doi.org/10.1016/..
 
?
7

Mediation of antitumor activity by AZD4820 oncolytic vaccin..:

Kurokawa, Cheyne ; Agrawal, Sonia ; Mitra, Abhisek...
Molecular Therapy: Oncology.  32 (2024)  1 - p. 200758 , 2024
Link: https://doi.org/10.1016/..
 
?
8

Analysis of SARS-CoV-2 Emergent Variants Following AZD7442 ..:

Kijak, Gustavo H. ; Ahani, Bahar ; Arbetter, Douglas...
Infectious Diseases and Therapy.  12 (2023)  12 - p. 2691-2707 , 2023
Link: https://doi.org/10.1007/..
 
?
9

Nirsevimab binding-site conservation in respiratory syncyti..:

Wilkins, Deidre ; Langedijk, Annefleur C ; Lebbink, Robert Jan...
The Lancet Infectious Diseases.  23 (2023)  7 - p. 856-866 , 2023
Link: https://doi.org/10.1016/..
 
?
10

Breakthrough SARS-CoV-2 Infections in the PROVENT Preventio..:

Tuffy, Kevin M ; Ahani, Bahar ; Aksyuk, Anastasia A...
The Journal of Infectious Diseases.  228 (2023)  8 - p. 1055-1059 , 2023
Link: https://doi.org/10.1093/..
 
?
11

Immune correlates analysis of a phase 3 trial of the AZD122..:

Benkeser, David ; Fong, Youyi ; Janes, Holly E....
npj Vaccines.  8 (2023)  1 - p. , 2023
Link: https://doi.org/10.1038/..
 
?
12

Immunogenicity and safety of AZD2816, a beta (B.1.351) vari..:

Ramasamy, Maheshi N ; Kelly, Elizabeth J ; Seegobin, Seth...
The Lancet Microbe.  4 (2023)  11 - p. e863-e874 , 2023
Link: https://doi.org/10.1016/..
 
?
13

1934. Nirsevimab is Associated with Higher and More Sustain..:

Wilkins, Deidre ; Hamrén, Ulrika Wählby ; Chang, Yue...
Open Forum Infectious Diseases.  10 (2023)  Supplement_2 - p. , 2023
Link: https://doi.org/10.1093/..
 
?
14

AZD1222-induced nasal antibody responses are shaped by prio..:

Aksyuk, Anastasia A. ; Bansal, Himanshu ; Wilkins, Deidre...
Cell Reports Medicine.  4 (2023)  1 - p. 100882 , 2023
Link: https://doi.org/10.1016/..
 
?
15

Robust humoral and cellular recall responses to AZD1222 att..:

Maaske, Jill ; Sproule, Stephanie ; Falsey, Ann R....
Frontiers in Immunology.  13 (2023)  - p. , 2023
Link: https://doi.org/10.3389/..
 
1-15